Revvity (RVTY) SG&A Expense (TTM): 784.19M | YCharts

Revvity, Inc. (RVTY)

150.83 -8.60 (-5.39%) USD | NYSE | Nov 05, 16:00

155.30 +4.47 (+2.96%) Pre-Market: 06:01

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.

Date	Value
September 30, 2026	784.19M
June 30, 2026	1.026B
March 31, 2026	996.05M
December 31, 2025	991.89M
September 30, 2025	984.49M
June 30, 2025	980.10M
March 31, 2025	983.22M
December 31, 2024	994.07M
September 30, 2024	1.006B
June 30, 2024	1.019B
March 31, 2024	1.035B
December 31, 2023	1.023B
September 30, 2023	1.010B
June 30, 2023	999.87M
March 31, 2023	996.04M
December 31, 2022	1.082B
September 30, 2022	1.121B
June 30, 2022	1.157B
March 31, 2022	1.175B
December 31, 2021	1.092B
September 30, 2021	1.072B
June 30, 2021	1.022B
March 31, 2021	960.74M
December 31, 2020	917.89M
September 30, 2020	865.58M

Date	Value
June 30, 2020	844.50M
March 31, 2020	825.03M
December 31, 2019	815.32M
September 30, 2019	815.12M
June 30, 2019	805.22M
March 31, 2019	806.04M
December 31, 2018	806.91M
September 30, 2018	772.75M
June 30, 2018	729.34M
March 31, 2018	675.02M
December 31, 2017	622.30M
September 30, 2017	608.72M
June 30, 2017	600.46M
March 31, 2017	603.36M
December 31, 2016	600.88M
September 30, 2016	596.60M
June 30, 2016	601.72M
March 31, 2016	597.51M
December 31, 2015	598.85M
September 30, 2015	656.99M
June 30, 2015	652.26M
March 31, 2015	652.77M
December 31, 2014	660.10M
September 30, 2014	585.40M
June 30, 2014	586.06M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Thermo Fisher Scientific, Inc.	8.812B
Danaher Corp.	8.117B
Agilent Technologies, Inc.	1.844B
Bruker Corp.	728.20M
Illumina, Inc.	1.136B